Influenza
319 results
1 - 100
Characteristics of patients with H1N1 influenza
Influenza vaccination during pregnancy is effective
Enhanced influenza vaccines prevent more hospitalizations than standard-dose influenza vaccines in older adults
Baloxavir is effective for influenza prophylaxis in household contacts
Influenza (H1N1) vaccination during pregnancy not associated with autism
Egg-allergic children can receive influenza vaccine
Adjuvant increases efficacy of influenza vaccine in infants and children
Antivirals can prevent influenza but treatment of symptoms is less impressive
Acute cardiovascular events are common in patients hospitalized with influenza
Surgical mask and N95 respirator similarly effective for preventing influenza
FluScoreVax incorporates vaccination history to accurately predict influenza risk
Rapid influenza tests reduce ER testing in kids, little else
Live attenuated influenza vaccine not effective in recent US flu seasons
Study confirms benefits of early administration of oseltamivir for hospitalized patients with influenza
Influenza vaccine during pregnancy not associated with adverse childhood health outcomes
Validated clinical decision rule to guide management for patients with suspected influenza
Further evidence no difference between N95 respirator and medical mask for influenza prevention
H1N1 influenza vaccination during pregnancy not associated with problems in exposed offspring
In adults with medical comorbidities, influenza vaccinations are associated with a lower risk of developing dementia
Anti-influenza drugs have no effect on mortality or hospitalization and reduce symptoms by 24 hours or less
Quadrivalent recombinant influenza vaccine seems safe and effective for adults older than 50 years
Avian influenza A(H5N1) generally causes mild illness in humans with no human-to-human spread in 46 cases
Same-day COVID-19 and seasonal influenza vaccines are as effective as each vaccine given separately
For adults presenting to the emergency department, mortality is 7.9% for COVID-19 (Omicron), 6.0% for RSV, and 2.5% for influenza
Low-certainty evidence suggests oseltamivir and peramivir may reduce hospital length of stay in adults with severe influenza
Influenza vaccine shortly after myocardial infarction reduces 1-year mortality (NNT = 50)
High-dose influenza vaccine no more effective than the standard dose for adults with high-risk cardiovascular disease
Postexposure prophylaxis with direct antivirals is more effective than placebo or usual care in preventing symptomatic seasonal and zoonotic influenza
mRNA flu vaccine somewhat more effective at preventing influenza than standard vaccine in adults 18 to 64 years (NNI = 300)


